BV is a common infection, with about one in four women in the United States suffering from it. It can cause pain when urinating, swelling, and a foul odor in the vagina. It can also increase the risk of pelvic inflammatory disease, which can lead to infertility.
What does boric acid do to your discharge?
The standard treatment for BV is antibiotics. Usually, the cure rate is 70 to 80 percent after one month of treatment. However, boric acid bv treatment can recur in up to 50 percent of women. Depending on how recurrent the infection is, some women may require treatment three or more times a week for three months.
Currently, there are few studies that evaluate the effectiveness of boric acid for BV. However, the BASIC trial (Bacterial Vaginosis in Pregnancy) is a randomized double-blinded multicenter study of 240 women aged 16 to 50. It will determine if boric acid is safe for pregnant women.
Women participating in the study will receive a free medication. They will be instructed to keep a daily treatment diary and return to the clinic for follow-up examinations. They will be randomly assigned to one of three treatment groups. Each treatment group will be given a different antibiotic and an intrauterine device. The participants cannot be pregnant, menopausal, or have another vaginal infection.
The primary outcome measure is the Nugent score. This score is a z-based confidence interval that assesses the immediate effect of the H3BO3 on the infection at day 17. The researchers chose the Nugent score as the primary outcome measure because it reflects the most important outcome of the study.